Bringing Medical Devices into India: Your Practical Guide to CDSCO Rules
India’s medical device market is booming. Demand keeps rising for new diagnostic and treatment tools, and global manufacturers have noticed—India’s now a key destination for…
India’s medical device market is booming. Demand keeps rising for new diagnostic and treatment tools, and global manufacturers have noticed—India’s now a key destination for…
Innovation keeps industries moving forward, and organizations that put time and money into research and development are right at the center of India’s push for
PESO, or the Petroleum and Explosives Safety Organisation, stands as India’s central authority for keeping hazardous substances in check. They’re in charge of making sure
CPCB has moved from rule-making to enforcement on plastic EPR—Registered Environment Auditors, customs blocks, and crore-level penalties are now live. Here’s what producers and importers must do.
Regulatory compliance has always been the backbone of a trustworthy supply chain, but a recent directive from the Central Drugs Standard Control Organization (CDSCO) highlights
CDSCO Bans 16 Fixed Dose Combinations: What Pharma Companies Need to Know Effective June 11, 2026, the Central Drugs Standard Control Organisation (CDSCO) has banned
CDSCO Releases Final Guidance on Medical Device Software under MDR 2017: What You Need to Know Published: July 2026 On 21 July 2026, the Central
DPIIT’s June 2026 footwear QCO amendments extend the legacy stock sell-off deadline to July 31, 2027 and ease R&D import rules. Here’s what footwear businesses must do now.
FSSAI’s March 2026 licensing overhaul and milk-sector advisory bring perpetual licences, new turnover slabs, and high-risk inspections for dairy. Here’s what dairy FBOs must do now.